Sept 19 (Reuters) - Hong Kong-listed CSPC Pharmaceutical
said on Thursday it would buy back shares worth up to HK$5 billion ($640 million) in the next two years.
($1 = 7.7931 Hong Kong dollars)
(Reporting by Sneha Kumar; Editing by Anil D'Silva)
((Sneha.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.